SCHEMBL2592704

SCHEMBL2592704

CC(C)(C)OC(=O)N1CCC2(CC1)Oc1ccccc1C(=O)C2CCO

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.41
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
IDO1 P14902 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
BACE1 P56817 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
ATM Q13315 1/20 0.38
CCR5 P51681 1/20 0.38
TACR1 P25103 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14972719 0.85 EPHX2 (0.38) ATM
SCHEMBL3492775 0.84 GPR119 (0.43) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL3492773 0.84 GPR119 (0.43) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL2590439 0.83 GPR119 (0.42) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL2596043 0.82 GPR119 (0.41) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL2591066 0.80 TSHR (0.44) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL2592446 0.79 GPR119 (0.38) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL21397530 0.76 HDAC3 (0.45) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL10258300 0.75 ATM (0.43) GPR119ATM
SCHEMBL3702583 0.75 ATM (0.56) GPR119ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595989-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2013-05-29 EP disclosed
WO-2011140425-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-10 WO disclosed